Creating, Staffing and Managing an Inspection War Room Your First Line of Defense

Quantity Discounts
1 - 9999
1 - 9999
1 - 9999
1 - 9999
We’ve all heard the basic “How to Prepare for an Inspection” presentation.  And we’ve heard your cries of “more detailed presentations, more specifics” on how to manage inspections.

On Thursday, Nov. 8, FDAnews presented one of the year’s most anticipated — and detailed — webinars on inspectional preparedness. And now you can listen with this special encore presentation.

Register Today

Too often, firms slap together what is essentially the central nervous system of their inspections.  There’s no forethought into the who, what, where, why and how behind every good inspection is a good war room.

Recently, during a drug company inspection, a heated argument broke out — in front of an FDA inspector — between two employees who disagreed on their own company procedures.  Don’t let this happen to you.

If you can’t confidently answer the following questions, register now for this special encore presentation.

  1. Who is going to be in your war room and how should you determine assigned roles and seniority?
  2. Who is responsible for guiding the FDA around a site? FDA investigators hate the “hordes” that follow them.
  3. What kinds of information should you provide — and what’s off limits to the FDA?
  4. What is considered privileged material or trade secrets and can you back your position up?
  5. If the FDA asks about the price of a product or what you pay for a good or service, are you going to respond?
  6. Photos within your facility? Yes or no? Either response has serious implications.

Register now.

Participants include everyone who is a key player in hosting FDA inspections, including:

  • Senior Management
  • Regulatory Affairs
  • QA/QC
  • Subject Matter Experts
  • Inside and Outside Counsel
  • Manufacturing Management/Supervision
  • Laboratory Management/Supervision

Dr. Darshan Kulkarni is the principal attorney at the Kulkarni Law Firm. He focuses on strategic regulatory and pharmaceutical counseling and has extensive experience handling the needs of international pharmaceutical, biopharmaceutical, and medical device companies and their service providers, including contract manufacturing organizations and contract research organizations. As corporate counsel for a reputable, international pharmaceutical holding company, Darshan provided corporate and regulatory legal advice to international pharmaceutical, biotech, and medical device companies. He has had experience in corporate quality control and has worked in varying legal and regulatory areas, including crafting responses to FDA 483s, FDA recalls, and negotiating with and for CROs and sponsors. Dr. Kulkarni has worked as a pharmacist for more than 10 years in multiple capacities, including hospitals, retail pharmacies, managed care, and has even participated as a clinician in clinical trials.

Register now!

Date: Nov. 12–30, 2012
Location: Your office or conference room (no need to travel!)
Time: Anytime

Gather your team for maximum benefit! Your investment is for one dial-in.

Interested in registering multiple sites?

Significant tuition discounts are available for three or more sites from
the same company. You must register at the same time and
provide a single payment to take advantage of the discount. Register below
by clicking on add to cart and then change your quantity in the shopping cart.
The discount will be calculated automatically.

3-4 sites – 10%
7-9 sites – 20%
5-6 sites – 15%
10+ sites – 25%

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally
with any questions.

We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Registrations may not be cancelled.Please contact customer service to make any substitutions.

Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.